~13 spots leftby Dec 2027

Early Life Interventions for Sickle Cell Disease

Recruiting in Palo Alto (17 mi)
Overseen byBrandi M Pernell, DNP, MSPH
Age: 18 - 65
Sex: Female
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Alabama at Birmingham
No Placebo Group

Trial Summary

What is the purpose of this trial?This study is being conducted to determine the relationship between early childhood exposures, such as Adverse Childhood Experiences, Social Determinants of Health and nutrition/breastfeeding, among children with sickle cell disease, and behavioral interventions aimed to reshape psychological resilience and lifestyle factors towards positive health outcomes.

Eligibility Criteria

This trial is for mothers of infants with sickle cell disease living near Birmingham, Alabama. They should have reliable internet access and not be on medications that can cause birth defects.

Inclusion Criteria

I am the mother of a baby with sickle cell disease.
Resides within the city of Birmingham, Alabama or in close proximity

Exclusion Criteria

I am taking medication that can harm a pregnancy.
No/limited internet access

Participant Groups

The study looks at how early life experiences affect children with sickle cell disease. It includes a breastfeeding support group to see if it helps build resilience and improve health outcomes.
2Treatment groups
Experimental Treatment
Group I: Observation GroupExperimental Treatment1 Intervention
A 24 month observation of 10 mother-infant dyads affected by sickle cell disease that initiate breastfeeding. These dyads will observed for breastfeeding exclusivity/dosage and duration. We obtain whole blood specimens for analysis of oxidative stress and inflammation at 3, 6, 12 and 24 months.
Group II: Breastfeeding Intervention GroupExperimental Treatment1 Intervention
Ten mother-infant dyads will be recruited to a six-month, community-based intervention aimed to promote sustained breastfeeding for at least six months among mothers of infants with sickle cell disease. The intervention will include an online, social media-based support group, online educational modules, monthly in-person educational sessions, access to free breast pump rentals, and monthly peer-led home visits by certified Vanderbilt-affiliated Maternal Infant Health Outreach Specialists. We obtain whole blood specimens for analysis of oxidative stress and inflammation at 3, 6, 12 and 24 months.

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
University of Alabama at BirminghamBirmingham, AL
Loading ...

Who Is Running the Clinical Trial?

University of Alabama at BirminghamLead Sponsor

References